Beyond accuracy: Creating a comprehensive evidence base for tuberculosis diagnostic tools

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 12, 2010, Pages 1518-1524

  Mann, Gillian Hazel ^a   Squire, S B ^a   Bissell, K ^b   Eliseev, P ^c   Du Toit, E ^d   Hesseling, A ^d   Nicol, M ^e   Detjen, A ^b   Kritski, A ^f  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c Arkhangelsk Regional Anti tuberculosis Dispensary   (Russian Federation)

^d Desmond Tutu HIV Centre   (South Africa)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^f Rede TB   (Brazil)

Author keywords

Diagnostics; Evidence; Impact; Policy; Tuberculosis

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; POLICY MAKING; RESEARCH; TUBERCULOSIS;

EID: 78649346537     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Stop TB Partnership, World Health Organization. The global plan to stop TB 2006-2015. Geneva, Switzerland: WHO, 2006.
2. World Health Organization Stop TB Partnership New Diagnostics Working Group. Pathways to better diagnostics for tuberculosis: a blueprint for the development of TB diagnostics. Geneva, Switzerland: WHO, 2009. http://whqlibdoc.who.int/publications/2009/9789241598811-eng.pdf Accessed September 2010.
3. World Health Organization Special Programme for Research and Training in Tropical Diseases/Foundation for Innovative New Diagnostics. Diagnostics for tuberculosis: global demand and market potential. Geneva, Switzerland: WHO, 2006.
4. World Health Organization. Moving research findings into new WHO policies. Geneva, Switzerland: WHO, 2008. http://www.who.int/tb/dots/laboratory/ policy/en/index4.html Accessed September 2010.
5. Guyatt G H, Oxman A D, Vist G, et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.
6. Guyatt G H, Oxman A D, Kunz R, et al. Rating quality of evidence and strength of recommendations: what is 'quality of evidence' and why is it important to clinicians? BMJ 2008; 336: 995-998.
7. Schunemann H J, Oxman A D, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336: 1106-1110.
8. Guyatt G H, Oxman A D, Kunz R, et al. Rating quality of evidence and strength of recommendations: incorporating considerations of resources use into grading recommendations. BMJ 2008; 336: 1170-1173.
9. Guyatt G H, Oxman A D, Kunz R, et al. Rating quality of evidence and strength of recommendations: going from evidence to recommendations. BMJ 2008; 336: 1049-1051.
10. Pai M, Ramsay A, O'Brien R. Evidence-based tuberculosis diagnosis. PLoS Med 2008; 5: 1043-1049.
11. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010; 16: 271-284.
12. Pai M, Ramsay A, O'Brien R J. Comprehensive new resource for evidence-based TB diagnosis. Expert Rev Mol Diagn 2009; 9: 637-639.
13. Marais B J, Raviglione M C, Donald P R, et al. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010; 375: 2179-2191.
14. Stop TB Partnership, World Health Organization Retooling Task Force. New technologies for tuberculosis control: a framework for their adoption, introduction and implementation. WHO/HTM/STB/2007.40. Geneva, Switzerland: WHO, 2007.
15. Organisation for Economic Cooperation and Development-Development Assistance Committee (OECD-DAC). Glossary of key terms in evaluation and results-based management proposed harmonized terminology. 2002. Paris, France: OECDDAC, 2002. http://www.undg.org/index.cfm?P=224 Accessed September 2010.
16. Wilkinson D, Newman W, Reid A, Squire S B, Sturm A W, Gilks C F. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis 2000; 4: 513-518.
17. Mundy C J F, Harries A D, Banerjee A, Salaniponi F M L, Gilks C F, Squire S B. Quality assessment of sputum transportation, smear preparation and AFB microscopy in a rural district in Malawi. Int J Tuberc Lung Dis 2002; 6: 47-54.
18. Mundy C J F, Bates I, Nkhoma W, et al. The operation, quality and costs of a district hospital laboratory service in Malawi. Trans R Soc Trop Med Hyg 2003; 97: 403-408.
19. Squire S B, Belaye A K, Kashoti A, et al. 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 2005; 9: 25-31.
20. Ramsay A, Squire S B, Siddiqi K, Cunningham J, Perkins M. The bleach microscopy method and case detection for TB control. Int J Tuberc Lung Dis 2006; 10: 256-258.
21. Cambanis A, Yassin M A, Ramsay A, Squire S B, Arbide I, Cuevas L E. A one-day method for the diagnosis of pulmonary tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis 2006; 10: 230-232.
22. Kemp J R, Mann G H, Nhlema Simwaka B, Salaniponi F M L, Squire S B. Can Malawi's poor afford free TB services? Patient and household costs associated with a TB diagnosis in Lilongwe. Bull World Health Organ 2006; 85: 580-585.
23. Liu X, Thomson R, Gong Y, et al. How affordable are TB diagnosis and treatment in rural China? An analysis from community and TB patient perspectives. Trop Med Int Health 2007; 12: 1464-1471.
24. Theobald S, Taegtmeyer M, Squire S B, et al. Towards building equitable health systems in sub-Saharan Africa: what can we learn from case studies on operational research? Health Res Pol Syst 2009; 7: 26.
25. Ramsay A, Cuevas L E, Mundy C, et al. New policies, new technologies: modelling the potential for improved smear microscopy services in Malawi. PLoS ONE 2009; 4: e7760.
26. World Health Organization, The Stop TB Partnership. The Stop TB strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva, Switzerland: WHO, 2006.
27. Yagui M, Perales M T, Asencios L, et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis 2006; 10: 838-843.
28. Ramsay A, Bonnet M, Gagnidze L, Githui W, Varaine F, Guerin P J. Sputum sex and scanty smears: new case definition may reduce sex disparities in smear-positive tuberculosis. Int J Tuberc Lung Dis 2009; 13: 613-619.
29. Harries A D, Michongwe J, Nyirenda T E, et al. Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi. Int J Tuberc Lung Dis 2004; 8: 204-210.
30. Gwatkin D R. Health inequalities and the health of the poor: what do we know? What can we do? Bull World Health Organ 2000; 78: 3-18.
31. Christensen C M. The innovator's dilemma: when new technologies cause great firms to fail. Boston, MA, USA: Harvard Business School Press, 1997.
32. Blumstein C, Goldstone S, Lutzenhiser L. A theory-based approach to market transformation. Energy Policy 2000; 28: 137-144.
33. World Health Organization. New WHO policies. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/dots/laboratory/policy/en/index.html Accessed September 2010.
34. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF Assay. J Clin Microbiol 2010; 48: 2495-2501.
35. Wagstaff A. Socio-economic inequalities in child mortality: comparisons across developing countries. Bull World Health Organ 2000; 78: 19-29.
36. Lönnroth K, Holtz T H, Cobelens F, et al. Inclusion of information on risk factors, socio-economic status and health seeking in a tuberculosis prevalence survey. Int J Tuberc Lung Dis 2009; 13: 171-176.
37. Muniyandi M, Rajeswari R. Socio-economic inequalities of tuberculosis in India. Expert Opin Pharmacother 2008; 9: 1623-1628.
38. Zwarenstein M, Treweek S, Gagnier J J, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008; 337: a2390.